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Streptomyces sp. strain NTK 937 is the producer of the benzoxazole antibiotic caboxamycin, which has been shown to exert in-
hibitory activity against Gram-positive bacteria, cytotoxic activity against several human tumor cell lines, and inhibition of the
enzyme phosphodiesterase. In this genome announcement, we present a draft genome sequence of Streptomyces sp. NTK 937 in
which we identified at least 35 putative secondary metabolite biosynthetic gene clusters.
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Streptomyces sp. strain NTK 937 was isolated from an AtlanticOcean deep-sea sediment core collected in 2001 at the south-
ern edge of the Saharan debris flow near the Canary Islands, at a
depth of 3,814 m (1). This strain produces the benzoxazole anti-
biotic caboxamycin (1), whose core structure is part of other cy-
totoxic benzoxazoles, such as UK-1 (2), AJI9561 (3), and nataxa-
zole (4). The cytotoxic activity of caboxamycin is lower than that
of UK-1, but in contrast to UK-1 (2), it shows antibiotic activity
against Gram-positive bacteria (1). In addition, caboxamycin was
found to be an inhibitor of phosphodiesterases, regulators of cy-
clic nucleotide signaling, and potential targets for treating asth-
matic inflammation and chronic obstructive pulmonary disease
(1).
Here, we present the draft genome sequence of the caboxamy-
cin producer strain generated by real-timeDNA sequencing using
the PacBio RS II platform (5). After the sequencing runs, a total of
77,344 paired-end sequences were obtained, with a mean of 5,551
nucleotides, which gave us a total of 429.34 Mb. A de novo assem-
bly was performed using a preassembly byHGAP version 2.0.2 (6)
and a final assembly using the whole-genome shotgun (WGS)-
Celera Assembler version 7.0 (7), followed by an assembly polish-
ing with theQuiver algorithm (8). The final assembly resulted in 3
contigs, the largest being 7,003,153 nucleotides and the shortest
18,266 nucleotides. The initial draft genome contains 7,444,861
nucleotides at 57.67-fold coverage, with a GC content of
71.90%. The annotation was performed using the PGAAP pipe-
line (9), resulting in the identification of 6,134 coding sequences,
18 rRNA operons, and 81 tRNA loci.
We searched the genome sequence of the Streptomyces sp. NTK
937 chromosome using the bioinformatic tool antiSMASH 2.0
(10) and found 35 predicted secondary metabolite biosynthetic
gene clusters. Fourteen of these clusters containmodular enzyme-
coding genes, such as genes for polyketide synthases (PKS) (4 type
I and 1 type II PKS), nonribosomal peptide synthetases (NRPS) (5
clusters), or hybrid PKS-NRPS (4 clusters). Thirteen clusters
might be involved in the biosynthesis of other peptides or amino
acid compounds, such as siderophores (1 cluster), ribosome-
derived peptides (3 lantipeptides and 8 bacteriocins), and ectoine
(1 cluster). The remaining eight gene clustersmight be involved in
the biosynthesis of terpenes (6 clusters), butyrolactone (1 cluster),
and melanin (1 cluster).
The Streptomyces sp. NTK 937 genome sequence will allow the
identification of a caboxamycin biosynthesis gene cluster for in-
vestigation of its pathway and generation of novel derivatives us-
ing combinatorial biosynthesis and genetic tools gathered from
other benzoxazole pathways. Furthermore, this chromosome is a
good candidate for genomemining of new gene clusters and other
bioactive compounds.
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited inDDBJ/EMBL/GenBank un-
der the accession no. JJOB00000000. The version described in this
paper is the first version, JJOB01000000.
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